Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
Cell Therapy News
Cell Therapy News is an online resource dedicated to sharing the latest cell therapy, gene therapy, and regenerative medicine research.
CD3 Aptamers Promote Expansion and Persistence of Tumor-Reactive T Cells for Adoptive T Cell Therapy in Cancer
[Molecular Therapy - Nucleic Acids] To identify CD3-specific T cell agonists, several RNA aptamers were selected against CD3 using SELEX combined with high-throughput sequencing.
Selective Refueling of CAR T Cells Using ADA1 and CD26 Boosts Antitumor Immunity
[Cell Reports Medicine] Scientists presented a metabolic refueling approach using inosine as an alternative fuel. CAR T cells were engineered to express membrane-bound CD26 and cytoplasmic adenosine deaminase 1 (ADA1), converting adenosine to inosine.
Controlling CAR T Cell Activity and Specificity with Synthetic SparX Adapters
[Molecular Therapy] Researchers developed a controllable cell therapy where synthetic D-Domain-containing proteins (SparX) bind one or more tumor antigens and mark those cells for elimination by genetically modified T cells
Live-Attenuated Virus Vaccine Defective in RNAi Suppression Induces Rapid Protection in Neonatal and Adult Mice Lacking Mature B and T Cells
[Proceedings Of The National Academy Of Sciences Of The United States Of America] The mosquito-transmitted Nodamura virus was attenuated in mice by mutations that prevent expression of the B2 viral suppressor of RNA interference and consequently, drastically enhance in vivo production of the virus-targeting small-interfering RNAs.
Cell Culture on Suspended Fiber for Tissue Regeneration: A Review
[International Journal Of Biological Macromolecules] The authors compare the effectiveness of 3D suspended fiber scaffolds with 2D culture systems, discussing their respective benefits and limitations in the context of tissue regeneration.
CT-Visible Microspheres Enable Whole-Body In Vivo Tracking of Injectable Tissue Engineering Scaffolds
[Advanced Healthcare Materials] An injectable tissue engineering scaffold consisting of highly porous microspheres compatible with transplantation of cells was modified to contain the computed tomography contrast agent barium sulphate.
Comparative Performance of scFv-Based Anti-BCMA CAR Formats for Improved T Cell Therapy in Multiple Myeloma
[Cancer Immunology Immunotherapy] CD8TM.41BBIC-based anti-BCMA CAR vectors with either a long linker or a short linker between the light and heavy scFv chain, CD28TM.41BBIC-based and CD28TM.CD28IC-based anti-BCMA CAR vector systems were used in primary human T cells.
Network Meta-Analysis of CAR T-Cell Therapy for the Treatment of 3L+ R/R LBCL After Using Published Comparative Studies
[Expert Review Of Anticancer Therapy] Scientists highlight important differences in clinical outcomes between CAR T-cell therapies. Axi-cel demonstrated improved overall survival compared to tisa-cel and liso-cel, and both axi-cel and liso-cel showed higher response rates compared to tisa-cel.
PolyU Collaborates With Axis Therapeutics to Establish Joint Laboratory for Immunotherapy
[Hong Kong Polytechnic University (EurekAlert!)] The Hong Kong Polytechnic University has entered into a formal collaboration with Axis Therapeutics to foster cancer immunotherapy research and development, with the aim of improving cancer treatment for patients in Hong Kong.
Development of a Compact Bidirectional Promoter-Driven Dual Chimeric Antigen Receptor (CAR) Construct Targeting CD19 and CD20 in the Sleeping Beauty (SB) Transposon System
[Journal For Immunotherapy Of Cancer] The authors developed a second-generation CAR directing CD19 and CD20 antigens, incorporating them in a head-to-head orientation from a bidirectional promoter using a single Sleeping Beauty transposon system.
CAR Affinity Modulates the Sensitivity of CAR-T Cells to PD-1/PD-L1-Mediated Inhibition
[Nature Communications] The authors interrogated CAR-T cells targeting HER2 with either low or high affinity in various preclinical models.
UCSF Launches Clinical Trial on New CAR T Therapy for Glioblastoma
[Insider Precision Medicine] Researchers at the University of California, San Francisco (UCSF) have begun enrollment for a clinical trial that uses a new, powerful version of CAR T as a potential therapy for glioblastoma, the most common and deadly adult brain cancer.
Published since 2002, Cell Therapy News is our longest running online publication. Our editorial team curates the top publications, reviews, and news on in vivo gene therapy, cell therapy, and immunotherapy research. With over 15,000 subscribers and followers across our website, email newsletter, and Twitter feed, we are proud to facilitate the communication of cutting-edge cell therapy innovations.
